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Topic Relevance by Timeline 
Summary 
● Software, such as mobile device apps or telemedicine, creates exciting new opportunities 
for patient engagement and for improving healthcare. 
● There are three main types of mobile apps: native, web, and hybrid. 
● The wireless technologies in smartphones and wearable sensors, such as smartwatches, 
offer the potential for additional biometric data collection. 
● HIPAA compliance requires multiple levels of oversight and auditing. 
● The software development costs for healthcare are considerably higher than for consumer-
oriented products due to FDA regulatory requirements; testing out proof-of-concept 
through low-cost alternatives is an important development strategy. 
Introduction 
Over the past several decades, there has been an explosive growth in the use of software in patient 
care. This growth has been catalyzed by the development of enhanced hardware platforms that 
substantially augment processing speed, improved protocol standardizations allowing for 
increased security, growing patient and provider acceptance, and insurance/government initiatives 
that encourage the use of digital health software, such as the electronic medical record. As a result, 
academic entrepreneurs are increasingly interested in this space. However, working in digital 
health carries a set of unique challenges related to software development and validation, as well as 
Food and Drug Administration (FDA) oversight. These topics will be discussed in this chapter; 
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while the primary focus is on smartphone app software, many of the core issues are relevant to 
other domains in digital health. 
FDA Categories 
The FDA broadly defines three categories of medical software (Center for Devices and 
Radiological Health):  
1. Software that by itself functions as a stand-alone medical device: Software as a Medical 
Device (SaMD). This may also be described as a digital therapeutic, or a prescription dig-
ital therapeutic. 
2. Software that is integral to the functioning of a physical medical device: Software in a 
Medical Device (SiMD). 
3. Software used in the manufacture or continued maintenance of a physical medical device. 
 
This chapter will be focusing on the first category, Software as a Medical Device. While Software 
as a Medical Device covers a broad range of potential applications, this type of software is increas-
ingly used in mobile apps, such as smartphone software applications, that could be used by patients 
and caregivers for the diagnosis, management, and/or treatment of health and medical conditions. 
 
The FDA exercises enforcement discretion on Software as a Medical Device that “pose minimal 
risk to patients and consumers” (Center for Devices and Radiological Health). These software 
functions include those that “help patients/users self-manage their disease or condition without 
providing specific treatment suggestions or automate simple tasks for health care providers” (Cen-
ter for Devices and Radiological Health). The determination whether or not to regulate is made on 
a case-by-case basis and can vary according to situation and platform. It is also important to note 
that other regulatory agencies, such as the Federal Trade Commission (FTC), also play an 
important role, as demonstrated by recent FTC fines against smartphone app developers for de-
ceptive advertising (“Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges 
for Its ‘Brain Training’ Program”).  
Potential Utility of Mobile Apps 
For over half a century, significant efforts and resources have gone into improving healthcare 
through the development of software applications, such as telemedicine (Doarn et al.). Software 
that directly engages patients has the potential for increased levels of patient engagement, a model 
of participatory healthcare (Figure 1) that could improve patient outcomes while also lowering 
cost.  
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Figure 1. Participatory Healthcare Model. 
 
 
Source: Adapted from Wensing and Elwyn (Wensing and Elwyn) 
 
In 2008, the iOS App Store completely transformed our relationship to software products through 
the creation of fully customizable, personal user experiences accessible from virtually anywhere 
in the world—i.e., the mobile app. Eleven years later, there are over five billion mobile users 
worldwide (“GSMA”). The ubiquity of mobile platforms in our everyday life has subsequently 
transformed mobile health (mHealth).  
 
The uniqueness of mHealth lies in the transformative potential of the mobile app. Mobile devices 
are engineered for portability and deep personalization. In many ways, one’s mobile device is more 
personal and private than their wallet, even as it simultaneously connects them to the wider world. 
Through active and passive data collection, mobile apps provide a means to continuously collect 
unique user data, process that data, and provide personal, data-based responses in near-real time. 
For clinical research, a mobile app could perform an ecological momentary assessment (EMA) at 
a randomized time or when the user meets some conditions, such as proximity to a specified GPS 
coordinate. For medical device trials, a mobile app’s ability to leverage device components—
including motion sensors, Wi-Fi, Bluetooth, and/or Near Field Communication (NFC)—provides 
a wide variety of ways to stay connected to a new medical device, running continuous analytics, 
data collection, or even big data processing on remote servers. 
App Development Options 
Through ongoing development and innovation, mobile apps have grown in complexity and design 
into three main categories: native apps, web apps, and hybrid apps. The main difference between 
these categories lies in their development. Ultimately, no one type of mobile app is better, faster, 
cheaper, or easier for all situations. However, for every research project hoping to include a mobile 
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app in any way, the choice of which mobile app type to use has drastic effects on timelines, budg-
ets, enrollments, and outcomes. The following descriptions of each mobile app type include key 
areas to consider when choosing to use a mobile app in a project. 
 
Native apps are typically written using a platform’s “native” programming language, i.e., Swift 
for Apple iOS and Kotlin for Google Android. For native apps, Apple and Google grant the ability 
to access all device features and capabilities through their proprietary frameworks, development 
tools, and application program interface (API), written specifically for their respective languages. 
These benefits are effectively to entice loyalty from developers. Although similar in nature, Swift 
and Kotlin are not interchangeable, nor is any of their code currently reusable in other environ-
ments (e.g., on a server); therefore, for a mobile app to have an iOS and an Android version, it 
must be completely written twice. Many businesses choose to target users on a single platform to 
start, adding support for other platforms after gaining some traction. Such a strategy may not be 
appropriate for research because it would create an additional inclusion/exclusion criterion and 
potentially bias the data. For instance, iOS users have an average salary of $53,251 and spend an 
average of about five hours on their mobile devices, while Android users have an average salary 
of $37,040 and only spend an average of about four hours on their devices (Slickdeals). Nonethe-
less, a common denominator for both platforms is the dominance of each platform’s proprietary 
app store. Having written an app using a particular platform’s native programming language, the 
developer must then submit it into the platform-specific app store for distribution, pending review. 
This review is an evaluation of the app’s functionality and user experience, and as such it is one 
of the most important parts of a native app. Because native apps are written in specific program-
ming languages, using proprietary tools, frameworks, and APIs, the respective app store is 
essentially the only means by which a native app can exist. Failure to meet the app store require-
ments can lead to a native app being removed from the app store. The ongoing review process of 
every app consists of multiple review periods. These review periods take time and must be 
accounted for in project timelines. A review period typically starts upon submission, regardless of 
whether it is an initial submission or an app update. However, Google and Apple regularly perform 
additional reviews of each app listing, to ensure that these apps continue to meet their require-
ments. While the duration of the review period may vary, each review period effectively ends with 
a pass or a fail. It is not uncommon for an updated app submission to fail multiple times even if it 
had passed previously.  
 
Research studies incorporating a mobile app can often take advantage of specific research and 
health-focused features a platform may offer, such as Apple’s Healthkit; these features are con-
stantly evolving, and thus a detailed discussion of them is beyond the scope of this chapter. 
However, there are some additional considerations that must be kept in mind that are relevant 
across platforms. Researchers must continue to attend to the maintenance of their mobile app, its 
user experience, and its status on the respective app stores to avoid interruptions in their availabil-
ity/accessibility. Maintenance of a native app includes publishing updates that account for and 
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incorporate updates and changes to all review guidelines and underlying tools, frameworks, and 
APIs. Maintenance of the user experience is not as straightforward. Over the past decade, Apple 
has continued to enforce stricter guidelines while shortening the average review period to about 
24 hours (Apple Inc, “App Review - App Store - Apple Developer”; Saying Goodbye to App 
Review Times – Dave Verwer’s Blog). The Google Play Store has gradually enforced stricter guide-
lines while extending the expected review period up to seven days in most cases (Toombs; Publish 
an App - Play Console Help). These changes are symptomatic of the oversaturation of the mobile 
app market. From the first 500 apps launched in 2008, the number of apps available on the Apple 
App Store grew to over 2.2 million in 2017, and the Google Play Store peaked at 3.6 million in 
March 2018. Both figures have since declined to 1.96 and 2.46 million, respectively (“Topic: 
Mobile App Usage”; Liao; Ariel). Google and Apple intentionally seek to curate their app stores, 
updating their guidelines and requirements regularly. Section 4.2 of Apple’s app development 
guidelines lists the minimum functionality of all apps, including those for research, on the Apple 
App Store: 
 
Your app should include features, content, and UI [user interface] that elevate it beyond a 
repackaged website. If your app is not particularly useful, unique, or “app-like,” it doesn’t 
belong on the App Store. If your App doesn’t provide some sort of lasting entertainment 
value, it may not be accepted. Apps that are simply a song or movie should be submitted 
to the iTunes Store. Apps that are simply a book or game guide should be submitted to the 
Apple Books Store … Apps created from a commercialized template or app generation 
service will be rejected unless they are submitted directly by the provider of the app’s con-
tent. These services should not submit apps on behalf of their clients and should offer tools 
that let their clients create customized, innovative apps that provide unique customer 
experiences. (Apple Inc, App Store Review Guidelines - Apple Developer) 
 
In short, a mobile app must have a unique, compelling reason to specifically be a native app and 
not a web app. An example of such a compelling reason could be the ability to leverage Bluetooth 
or Near Field Communication to integrate a user’s mobile device with some novel external sensor. 
Nonetheless, an app’s reason will be reevaluated by Apple and Google as they continue to refine 
the requirements of a native app to be listed on their respective app stores. Unfortunately, their 
reasoning of which apps have unique, compelling reasons and which do not will remain subject to 
their discretion. Furthermore, this requirement disproportionately affects leaner operations such as 
small businesses, community organizations, and pilot research projects that do not have the means 
or funds to invest months of development into creating and maintaining a high-quality app with a 
unique and compelling feature set. For example, there already exists an abundance of mHealth-
related native apps that simply administer a survey and/or present medically related information 
for educational and research purposes. Often, these apps are generated by some service or using 
some template. For instance, in November 2018 the Food and Drug Administration developed and 
released template code for creating these simple apps for Android and iOS (“New Real World 
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Evidence Digital Tool from FDA, MyStudies App”). The code is provided as is and does not guar-
antee passing the app store review. All of these apps must still offer a unique, compelling 
innovation beyond data presentation and collection to be considered fit for distribution on an app 
store. Essentially, an “app could be rejected just because the app store reviewer feels like there are 
already enough apps in [that] category” (Love, “How Is Apple Encouraging Progressive Web 
Apps?”). This tightening of criteria for native apps is an acknowledgment of the significant invest-
ment required to make a native app and an encouragement for developers to consider web apps for 
most simple use cases (Apple Inc, App Updates for HTML5 Apps - News - Apple Developer; 
Firtman, “Google Play Store Now Open for Progressive Web Apps”). 
 
Web apps are the result of recent innovations in internet browsers that allow web pages to be highly 
interactive and responsive. Currently, the progressive web app (PWA) is the most common stand-
ard for web apps. At its most basic level, any website can become a PWA by adding an app 
manifest and including a service worker. An app manifest is a single, “simple JSON [JavaScript 
Object Notation] file that tells the browser about your web application and how it should behave 
when ‘installed’ on the user’s mobile device or desktop” (“The Web App Manifest | Web Funda-
mentals | Google Developers”). A service worker provides the mobile device with many of the 
necessary tools and information to essentially “run” a specific website more like a native app. 
While compliance with the progressive web app specifications varies across devices, a single pro-
gressive web app can currently operate on mobile devices (iOS and Android) and desktop 
computers (Firtman, “iPhone 11, iPadOS and iOS 13 for PWAs and Web Development”). Instal-
lation of a progressive web app is done directly from the website, without an app store or an app 
store review process. At this time, certain abilities are still experimental and/or not implemented 
for all devices, such as access to Bluetooth and push notifications on iOS. Their functionality of-
fline is currently more limited than that of native apps. However, support is steadily growing, and 
Google now allows progressive web apps on the Google Play Store as Trusted Web Activities 
(Love, “Apple Safari Ships Service Worker & Progressive Web App Support”; Firtman, “Google 
Play Store Now Open for Progressive Web Apps”). A listing on the Google Play Store is particu-
larly helpful because users expect all mobile apps to come from an app store due to the current 
minimal market recognition of progressive web apps. 
 
Hybrid apps can be described as native app shells for web apps. They are an attempt to bridge the 
divide between native apps and web apps. At its most rudimentary implementation, a native app 
shell opens a browser window that displays the web app from either a website or from a JavaScript 
code that was bundled with the native app code. While hybrid apps generally have more access to 
the underlying mobile device than web apps, they are most commonly used as a means to distribute 
a web app via an app store since users have been trained to expect apps from app stores. There are 
multiple frameworks and services that will simultaneously generate the native app shell for both 
iOS and Android. Both versions would access the same web app. More advanced frameworks, 
such as React Native, create a bridge from the original JavaScript code to the native user interface 
6https://repository.upenn.edu/ace/vol1/iss3/19
(UI) components of the mobile device, essentially rendering to the screen like a native app instead 
of like a web page. These advanced frameworks tend to require much more overhead, leading to 
apps that are much larger in size and take longer to load than a basic native app (Peal, “React 
Native at Airbnb: The Technology”). Moreover, for some use cases, such as supporting complex 
gestures, the amount of additional bridging code necessary to facilitate communication between 
the React Native code and the native code can lead to essentially supporting three platforms (React 
Native, React Native to iOS bridging code, and React Native to Android bridging code) instead of 
the single hybrid platform (Peal, “Sunsetting React Native”). The growing complexity of the bridg-
ing code led to Airbnb moving from React Native to writing purely native apps in 2018. This is 
not to say React Native has no valid use cases. Both Instagram and Facebook use React Native, 
for example. Often, the average user does not notice the difference between a hybrid app and a 
native app. At the time of this writing, there are many hybrid apps on both the Apple App Store 
and Google Play Store. Nevertheless, hybrid apps must still pass the app store review to be listed. 
Passing may become increasingly more difficult because Apple wants to remove all hybrid apps 
that solely open a browser window to a web app, which they refer to as HTML5 apps, from the 
Apple App Store by March 3, 2020 (Apple Inc, App Updates for HTML5 Apps - News - Apple 
Developer). The remainder of this section will address mobile apps in general and is applicable to 
native, web, and hybrid apps. 
Opportunities for Data Integration with Biometric Sensors 
Research studies using or developing biometric sensors benefit greatly from an integration with a 
mobile app. Bluetooth Low Energy (BLE) and Near Field Communication (NFC) are two wireless 
technologies, readily available in most mobile devices, that help biometric sensors overcome their 
limited computational bandwidth, storage space, and battery life. Using these technologies, a bio-
metric sensor can quickly be “paired” with a mobile device. With an associated mobile app, data 
from the sensor can be streamed to the mobile device, which can store, process, and/or relay the 
data to a server for additional storage and processing. This process reduces the amount of local 
storage and computational bandwidth needed by a sensor. While a mobile app introduces an addi-
tional step in data retrieval from a sensor, the low energy consumption by BLE and NFC in 
comparison to Wi-Fi and cellular networks is often well worth the investment. 
Institutional Considerations 
Every mobile app should come with a user agreement that includes data use and privacy policies, 
especially those that handle sensitive information. The specifications within that user agreement 
can vary by institution. Each institution will have established software development best practices, 
in particular for Health Insurance Portability and Accountability Act (HIPAA) compliance. These 
best practices should be a part of the development process for a mobile app before any develop-
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ment even begins. Generally, these will include recommendations and requirements for data trans-
mission and data storage, assessments of security policies, delineation of maintenance and auditing 
responsibilities, and definition of acceptable use of internal and external resources. The 
recommendations and requirements for data transmission and data storage will generally mirror 
industry best practices for data encryption “at-rest” and “in-flight” and for multi-factor authenti-
cation. The assessments of security policies will cover how data breaches will be caught, mitigated, 
and reported. The delineation of maintenance and auditing responsibilities covers who will take 
responsibility of providing updates and bug fixes to the mobile app and its infrastructure (e.g., 
back-end servers) and who will track and review audit logs for suspicious activity, both malicious 
and bug related. Finally, the definition of acceptable use of internal and external resources 
establishes the kind of tools, services, and resources that a mobile app can use to mitigate a data 
breach and/or liability. For example, some institutions do not consider the use of Amazon Web 
Services servers as complying with HIPAA because of / resulting in the lack of a business associate 
agreement in place between the institution and Amazon (Office for Civil Rights (OCR)). This 
detail would be disastrous for a researcher to discover if their mobile app had already been built 
on Amazon Web Services. In this case, the researcher may need to substantially modify their data 
collection to limit it to de-identified data only, which will likely require discussion with the insti-
tution and the affiliated institutional review board (IRB). 
 
Most academic healthcare institutions are also using an electronic medical record (EMR). Integra-
tion of an app with the EMR can substantially leverage the large body of data in the EMR and its 
ease of access for clinicians and patients. However, most EMRs are tightly controlled and access 
can be challenging and time-consuming. Several initiatives exist to enhance interoperability with 
the EMR and other health IT systems, such as the Fast Healthcare Interoperability Resource 
(FHIR) specifications developed by the Health Level Seven International non-profit organization 
(SMART on FHIR). 
 
While digital health solutions often focus on the patient, it is also important to keep in mind the 
perspective of the healthcare provider when developing an effective software solution for deploy-
ment. Traditionally, healthcare providers have been reluctant to embrace digital health solutions 
for a variety of reasons (Figure 2); these must be addressed as part of the development cycle for 
an academic entrepreneur to successfully engage with this key stakeholder (see chapters on “Con-
ducting Insightful Market Research” and “Human-Centered Design: Understanding Customers’ 
Needs Through Discovery and Interviewing”). 
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Figure 2. Factors Driving Low Levels of New Technology Implementation by Healthcare 
Providers and Institutions. 
 
 
Intellectual Property 
Digital health innovations often take a different approach to intellectual property (IP) as compared 
to drugs or devices. Software may be copyrighted, but there are often multiple approaches to per-
forming a task, thus limiting the utility of a copyright to influence potential competitors from 
deciding to enter the space. In some cases, design patents can be used, but a competitor can easily 
find alternatives to those as well. In many cases, the startup team’s deep knowledge of the clinical 
area and their ability to rapidly execute remain key ways to mitigate the lack of formal IP protec-
tions in digital health.  
FDA Regulatory Oversight 
The FDA has provided guidance regarding when digital health, such as mobile apps, may require 
FDA certification: “if a software function is intended for use in performing a medical device 
function (i.e. for diagnosis of disease or other conditions, or the cure, mitigation, treatment, or 
prevention of disease) it is a medical device, regardless of the platform on which it is run” (Policy 
for Device Software Functions and Mobile Medical Applications—Guidance for Industry and 
Food and Drug Administration Staff). FDA oversight is also required when medical claims are 
made in marketing material. The FDA has enforcement discretion, which means that, in some 
cases, the FDA may decide that review is not required. Broad categories of apps that may require 
FDA review are shown in Figure 3. 
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Figure 3. Mobile Apps That May Require FDA Review. 
 
 
 
Traditional FDA certification pathways commonly used for mobile apps or digital health solutions 
require each product to be independently certified, such as through the 510(k) premarket notifica-
tion pathway. In addition to the FDA template code for simple apps mentioned earlier, the FDA 
has introduced a new model (Pre-Cert) where the software company’s development process is 
certified and will allow the company to create software devices without each new one undergoing 
its own FDA clearance/approval process. As described by FDA Commissioner Dr. Scott Gottlieb, 
it is intended for “certain novel types of low- to moderate-risk devices to obtain marketing author-
ization” (“FDA Looks to De Novo Pathway Model as It Unveils Updates to Pre-Cert Program”). 
 
For Pre-Cert, a software development company must undergo an excellence appraisal by the FDA 
first. This process includes evaluating quality system regulations (QRS) to demonstrate design 
control and validation. Dr. Gottlieb further clarified that the FDA “evaluat[es] the quality and 
excellence of the software developer for Pre-Cert. By collecting this information early, the Excel-
lence Appraisal could be leveraged to streamline a developer’s De Novo submission, reducing 
content the developer would need to submit to the agency under the De Novo pathway since the 
information would already have been demonstrated and documented during the Excellence 
Appraisal” (“FDA Looks to De Novo Pathway Model as It Unveils Updates to Pre-Cert Program”). 
 
Once a software development company has completed Pre-Cert, acceptable studies for SaMD ap-
proval are typically randomized trials. For example, Pear’s reset-O software was approved based 
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on the results of a single unblinded randomized trial of 170 participants, which also rigorously 
monitored safety (adverse events) as well as efficacy (“FDA Clears First Prescription Digital Ther-
apeutic for Opioid Use Disorder”). Additional guidance can be found in the “Software 
Precertification Program: Regulatory Framework for Conducting the Pilot Program within Current 
Authorities” document available at https://www.fda.gov/media/119724/download. 
Cost 
Developing a mobile app is similar to building a house. The cost will vary mainly by the level of 
customization, but any number of other factors might further shift the cost. If the desired feature 
set is simple enough, perhaps a cookie-cutter solution through an app generator might be best. 
However, as the feature set grows and becomes more original, the cost, timeline, and complexity 
will grow exponentially. This is because each feature will have to integrate to some degree with 
every other feature. Furthermore, features do not necessarily have to be additional components to 
the mobile app, but may also be on the back-end database or elsewhere; choices on the implemen-
tation of the back-end will affect more than just the cost, and thus merit additional discussion. 
 
The back-end is the central database that stores all user data. There are multiple approaches for 
implementing a back-end, and not every approach fits all situations. To start, a back-end must have 
a location; either it is physically hosted in house/on premise or in the cloud. An on-premise back-
end requires purchasing equipment, having a location to store and safeguard that equipment, and 
supporting the ongoing maintenance of the equipment. The physical proximity of the back-end to 
users will have a noticeable effect on data loading times. Meanwhile, cloud solutions have a variety 
of flavors, including Infrastructure as a Service (IaaS), Platform as a Service (PaaS), and server-
less. Infrastructure as a Service is the most comparable to in-house because it is effectively the 
contracting of a third party to host and manage all of the equipment that would be required for an 
in-house solution. A financial cost comparison of an in-house back-end versus one hosted with an 
Infrastructure as a Service is difficult to generalize for every situation. The internet has countless 
cost calculators, most from a cloud provider, all of which tend to disagree regarding the exact 
financial cost of any solution (“Total Cost of Ownership of Servers”; Deckler, “Cloud vs. On-
Premises - Hard Dollar Costs Revisited”; Deckler, “Cloud vs. On-Premises – Hard Dollar Costs”). 
Cloud providers often cite how their solutions scale more readily than in-house solutions because 
cloud providers already have the equipment available at data centers around the world. Further-
more, their Platform as a Service and serverless offerings reduce the amount of configuration 
needed to maximize use of their Infrastructure as a Service. Platform as a Service includes man-
aged tools and analytics—on top of Infrastructure as a Service—that can be helpful for knowing 
how many servers to provision and where to provision them (What Is PaaS? Platform as a Service 
| Microsoft Azure). Serverless solutions still use servers, but only when necessary. In-house, 
Infrastructure as a Service, and Platform as a Service all require servers to be running at all hours 
for an application to work. In contrast, serverless solutions provision the servers just in time when 
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they are needed by an application, in exchange for a small startup delay. Cloud providers only 
charge for the time a resource is in use.  
 
Aside from variances in the cost of each approach, the configuration of the back-end has legal, 
security, and compliance ramifications, even more so than the type of mobile app. While cloud 
solutions make the argument that they are easier to sustain than in-house solutions, they undoubt-
edly give developers and administrators less control of the data than an in-house solution. If 
protected health information is to be sent to or stored in a back-end built on servers owned by a 
cloud provider, a formal business associate contract must be in place for compliance with HIPAA 
(Office for Civil Rights (OCR)); this typically increases costs. See the Resources section for a 
sample contract. Jeff Thomas, CTO of Forward Health Group, explained this in an interview:  
 
HIPAA compliance is always a dangerous and very vast term and healthcare organizations 
should always be leery of anyone selling a HIPAA compliant solution [...] Even if a 
solution enables you to use it in a compliant manner, doesn’t necessarily mean it solves the 
compliance problem for you [...] Is the vendor you choose willing to sign a business 
associate agreement? If they hesitate or don’t know what that is, they aren’t the right vendor 
to choose because they don’t understand your healthcare compliance needs when it comes 
to HIPAA. (HITInfrastructure) 
 
Choices regarding the implementation of the back-end are just a tiny subset of all the choices that 
will affect the cost, timeline, and complexity of a mobile app. Unfortunately, there is the risk that 
cost estimates are thrown together based on optimistic guesses relying chiefly on anecdotal evi-
dence; this can fundamentally undermine a credible business plan presented to potential investors, 
thus an academic entrepreneur is best served by carefully thinking through the options and obtain-
ing multiple bids (see the chapter “Writing the Business Plan for a Life Science Startup or Clinical 
Program”). The remainder of this section will cover strategies that will generally help keep costs 
low and productivity high. 
 
First and foremost, at least in the short run, there is no software product that is cheaper to build 
than to buy. Buying a software tool is the same as buying groceries from the local supermarket. 
Building a software tool is like buying a farm to grow your own produce. A common concern with 
buying an off-the-shelf solution is the loss of customizability. The options at the supermarket are 
limited, while a farm offers the opportunity to grow virtually anything. However, is the use case 
so unique and innovative that not a single product on the market can work, albeit less than ideally? 
Carefully consider the true worth of any gain a custom product might provide within the duration 
of the project. In terms of mobile apps, verify if a well-reviewed app or website generator might 
be sufficient, especially when a startup is in the early development phase and a basic pretotype 
using existing tools in a novel way would suffice (see the chapter “Rapid Prototyping Strategies”). 
For example, a website generator will put together an app almost instantaneously through a few 
clicks, no programming involved. For academic entrepreneurs, in some cases a basic app can be 
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developed in a computer science class, but this process can be challenging because the class will 
eventually end and the development team will disperse. 
 
To determine whether a project can sustain a mobile app through gestation, consider the project’s 
elasticity. If the project is solely to develop the mobile app, this calculation is easy: multiply by 1. 
If the mobile app is a secondary component of the overall project, a rough estimate would be to 
consider whether the primary component of the project could still be reached in half the time and 
with half the funds. This is not to say, spend the first half of the project on developing the mobile 
app and the second half on using the mobile app, because it incorrectly assumes that the mobile 
app will work perfectly during the second half of the project. Instead, create a critical path schedule 
with the primary non-app component and the mobile app development running roughly concur-
rently. Account for the app’s continued maintenance. Bugs do not decrease linearly, but by some 
polynomial function. “The fundamental problem with program maintenance is that fixing a defect 
has a substantial (20–50 percent) chance of introducing another” (Brooks). Structure the mobile 
app’s development as incremental growth. Start with a program that simply opens but displays 
nothing; then incrementally develop more functionality (Brooks). These increments must be very 
small, specific, and rapidly prototyped. User authentication is not a small or specific feature; in-
stead consider creating a study form with pre-specified fields. If one has built a prototype with the 
desired feature, user tests will indicate more accurately the necessity of the feature, how long it 
would take to fully build the feature, its requirements, and its cost. Rampant in software 
engineering is the “assumption that one can specify a satisfactory system in advance, get bids for 
its construction, have it built, and install it” (Brooks). Instead, development of a mobile app should 
be seen as an iterative process that extends past the app’s release. Costs will continue to accrue so 
long as the app exists, thus the app developer’s history and cost overruns on past projects can be 
an important guide. Staying tightly engaged with the developers throughout each iteration would 
mean there will be fewer surprises regarding the costs or the timeline.  
Conclusion 
Digital health technologies offer tremendous potential for improving healthcare through their 
ability to engage patients and provide real-time data on medical conditions and treatment. Software 
can exist either as a medical device (Software as a Medical Device) or as part of an existing device 
(Software in a Medical Device). Mobile apps implemented through new smartphone devices and 
wearable sensors represent a growing field, especially due to their ubiquitous role in patients’ lives. 
There are several important regulatory considerations guided by the FDA that can influence the 
potential development and use of a specific device. Thus, developing a new digital health solution 
may often require careful consideration of the feature set and prototyping to confirm the value/util-
ity of specific features. 
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Resources 
1. The Mythical Man-Month by Frederick Brooks is a timeless guide for how to approach 
software engineering, outlining common misconceptions of how software is built and how 
to avoid common pitfalls.  
2. “HIPAA for Professionals”:  
https://www.hhs.gov/hipaa/for-professionals/index.html. This is an invaluable resource for 
any application in healthcare. 
3. Sample HIPAA contract, provided by the Department of Health and Human Services: 
https://www.hhs.gov/hipaa/for-professionals/covered-entities/sample-business-associate-
agreement-provisions/index.html. 
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